Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Vivo Opportunity, LLC. Director active across 4 companies, notably Sierra Oncology, Inc.. Aggregated, 18 filings have been logged. Split: 10 buys · 4 sells. Total volume traded: €110.5m. Activity tracked since 26 January 2022. The latest transaction was disclosed on 14 July 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Vivo Opportunity, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24,996 shares@ US$13.201.0% of flowCommon StockSEC:0001213900-22-004318:0
18 of 18 declarations
About Vivo Opportunity, LLC
Vivo Opportunity, LLC has filed 18 filings in total. Among the recent filings held, purchases amount to EUR 29987779 and sales to EUR 89027337, over the period from 2022-01-28 to 2026-07-16. The companies mentioned are InMed Pharmaceuticals Inc. as 10% Owner, Soleno Therapeutics INC, Terns Pharmaceuticals, Inc., and Sierra Oncology, Inc. as Director.